Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2-associated transcription factor 1, pseudogene (No canonical abbreviation is commonly used for this pseudogene; abbreviations like "BCLAF1P" or "BCLAF1 pseudogene" may be seen but are not standardized)
- Target
- No canonical abbreviation is commonly used for this pseudogene; abbreviations like "BCLAF1P" or "BCLAF1 pseudogene" may be seen but are not standardized
- Molecular classification
- Other (Pseudogene)
01
Overview
"BCL2-associated transcription factor 1, pseudogene" (ENSG00000271313) is a genomic segment highly similar to the functional BCLAF1 gene, but is annotated as a pseudogene and is considered non-protein-coding. Pseudogenes generally do not encode functional proteins and are not considered relevant for therapeutics or disease biology. In contrast, the functional BCLAF1 gene encodes a transcriptional repressor associated with apoptosis and cancer biology, but this pseudogene is not known to contribute to those functions
- Other names
- BCLAF1 pseudogeneBCL2-associated transcription factor 1 pseudogeneBCLAF1P
02
Mechanism of action
None established. Pseudogenes are typically not modulated by drugs
03
Biological functions
None established for pseudogene
04
Disease associations
None established for pseudogene
05
Safety considerations
None established for pseudogene
06
Interacting drugs
None known.
07
Biomarkers
None established for pseudogene
Beyond the preview
Go deeper on BCL2-associated transcription factor 1, pseudogene (No canonical abbreviation is commonly used for this pseudogene; abbreviations like "BCLAF1P" or "BCLAF1 pseudogene" may be seen but are not standardized).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCL2-associated transcription factor 1, pseudogene (No canonical abbreviation is commonly used for this pseudogene; abbreviations like "BCLAF1P" or "BCLAF1 pseudogene" may be seen but are not standardized).